Harvard and Wyss Institute researchers created a two-layer hydrogel adhesive inspired by slug mucus, designed to stick to wet, moving tissue. Laboratory and animal tests showed promise for sealing injuries, but the work was a proof of concept and does not establish safety or effectiveness in people.
TLDR: A hydrogel adhesive inspired by slug mucus stayed attached to wet, moving tissue in laboratory tests and sealed injuries in animal experiments. Its two-layer design pairs a tough, flexible base with a tissue-gripping surface. The material remains experimental, with further safety and performance testing needed before any human use.
A soft, stretchy adhesive modeled on the mucus of a common slug has shown promise for sealing injured tissue, including in animal tests. The material, developed by researchers at Harvard University and the Wyss Institute for Biologically Inspired Engineering, was reported in the journal Science in 2017. Its design addresses a stubborn challenge in surgery: getting an adhesive to stay attached to wet, moving tissue without causing additional damage.
Many medical glues lose their grip in the body’s watery environment, while stitches and staples can injure fragile tissue. The researchers sought a material that could adhere strongly, stretch with organs, and remain compatible with the body. Their inspiration was the dusky Arion slug, which produces mucus that helps it cling to surfaces even when disturbed.
The resulting hydrogel has two layers. A tough, porous base is made from alginate, a material derived from seaweed, and polyacrylamide, a water-absorbing polymer. The base can deform with tissue and dissipate force. A thin adhesive surface contains positively charged polymers that interact with negatively charged molecules on biological tissue. Together, the layers combine a strong bond with flexibility.
In laboratory tests, the adhesive attached to tissues including skin, cartilage, heart, artery and liver. It remained attached when stretched or twisted and could bond in wet conditions. The team also tested it in animals, using it to seal a hole in a pig’s heart and to stop bleeding from a rat’s liver. Those experiments showed that the material could work on organs that move or are difficult to dry before treatment.
The work was led by researchers in materials science and bioengineering, including Jianyu Li, then a postdoctoral researcher at Harvard’s John A. Paulson School of Engineering and Applied Sciences. The researchers described the adhesive as biocompatible in the tests reported, and found that it could be removed from tissue without the same degree of damage associated with some existing adhesives. The study was a proof of concept, not a clinical trial, and did not establish that the material is safe or effective in people.
The layered construction is central to the approach. A very strong but rigid glue could tear tissue as an organ expands and contracts; a soft material might stretch but detach. By separating the functions, the hydrogel’s base provides mechanical toughness while its surface makes contact with tissue. The balance could matter in applications such as wound closure, surgical repair and sealing internal injuries, where movement and moisture can undermine conventional methods.
The study also illustrates how biological observations can inform materials engineering without requiring a direct copy of an organism. Slug mucus supplied a useful principle—adhesion that holds under wet, shifting conditions—while the researchers built a synthetic material from components selected for their mechanical and biological properties. The work drew attention because it combined a familiar animal’s unusual strategy with a practical problem faced in operating rooms.
Important questions remain before a material like this could be used routinely. Researchers would need to establish how it behaves over longer periods, how the body breaks it down or responds to it, and whether it can be manufactured consistently for medical use. Further testing would also need to compare its performance with established surgical adhesives and repair methods across different types of tissue.
The researchers presented the hydrogel as a versatile platform rather than a finished medical product. If later studies confirm its safety and effectiveness, a tissue-friendly adhesive that holds in wet, moving environments could give surgeons another way to close wounds or repair delicate organs. The next steps are rigorous preclinical evaluation, refinement for specific procedures and, eventually, carefully controlled human studies.
Susan Carter serves as a Senior Correspondent for Just Right News, where she leads the network’s comprehensive coverage of Health, Medicine, and Public Policy. With a career dedicated to dissecting the complexities of the American healthcare system, Susan brings a principled perspective to the most pressing debates of the day. Her reporting is characterized by a commitment to individual liberty, fiscal responsibility, and a healthy skepticism of government overreach, making her a vital voice for audiences seeking clarity in an increasingly regulated landscape.
Raised in Minneapolis, Minnesota, Susan’s professional outlook is deeply informed by the values of the American heartland. Growing up in the Twin Cities, she witnessed firsthand the importance of community-driven solutions and the resilience of the individual. This Midwestern foundation instilled in her a firm belief that the best answers to public policy challenges often come from local innovation and personal responsibility rather than top-down federal mandates. Her background allows her to translate complex legislative jargon into stories that resonate with families who value common sense and local autonomy.
Now based in Baltimore, Maryland, Susan operates from a unique vantage point at the intersection of medical innovation and urban policy. Living and working in a city renowned for its world-class medical institutions and significant public health challenges, she has a front-row seat to the realities of the modern healthcare landscape. Her proximity to these hubs of research and policy allows her to scrutinize how government intervention affects the quality of care and the freedom of medical professionals. In Baltimore, she sees the tangible results of policy decisions, using the city as a lens through which to examine the broader national health debate and the impact of federal spending on local communities.
As the lead for the acclaimed feature series “The Cost of Care,” Susan dives deep into the economic realities facing patients and providers alike. Her work focuses on the necessity of price transparency, the benefits of market competition, and the preservation of the sacred doctor-patient relationship. She is a staunch advocate for the idea that a well-informed public is the best defense against bureaucratic inefficiency. Through this series, she has exposed the hidden drivers of rising medical expenses, always seeking to empower the individual consumer over the massive institution.
Susan’s reporting on public policy is characterized by a commitment to rigorous inquiry and a focus on constitutional limits. Whether she is analyzing new pharmaceutical regulations, investigating the impact of federal health mandates, or exploring the future of medical technology, her goal remains the same: to provide Just Right News audiences with the facts they need to navigate a complex world. By blending her Midwestern sensibilities with the insights gained from her base in Maryland, Susan Carter has become a trusted authority for those who believe that personal freedom and public health are inextricably linked. Her work continues to challenge the status quo, advocating for a system that respects the taxpayer and prioritizes the patient.